CLDX
Price
$26.41
Change
+$0.56 (+2.17%)
Updated
Oct 3 closing price
Capitalization
1.75B
31 days until earnings call
CRNX
Price
$40.86
Change
-$0.65 (-1.57%)
Updated
Oct 3 closing price
Capitalization
3.85B
32 days until earnings call
Interact to see
Advertisement

CLDX vs CRNX

Header iconCLDX vs CRNX Comparison
Open Charts CLDX vs CRNXBanner chart's image
Celldex Therapeutics
Price$26.41
Change+$0.56 (+2.17%)
Volume$967.49K
Capitalization1.75B
Crinetics Pharmaceuticals
Price$40.86
Change-$0.65 (-1.57%)
Volume$1.39M
Capitalization3.85B
CLDX vs CRNX Comparison Chart in %
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. CRNX commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Buy and CRNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 05, 2025
Stock price -- (CLDX: $26.41 vs. CRNX: $40.86)
Brand notoriety: CLDX and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 72% vs. CRNX: 95%
Market capitalization -- CLDX: $1.75B vs. CRNX: $3.85B
CLDX [@Biotechnology] is valued at $1.75B. CRNX’s [@Biotechnology] market capitalization is $3.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLDX and CRNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 7 TA indicator(s) are bullish while CRNX’s TA Score has 5 bullish TA indicator(s).

  • CLDX’s TA Score: 7 bullish, 3 bearish.
  • CRNX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than CRNX.

Price Growth

CLDX (@Biotechnology) experienced а +1.03% price change this week, while CRNX (@Biotechnology) price change was -11.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

CLDX is expected to report earnings on Nov 05, 2025.

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.85B) has a higher market cap than CLDX($1.75B). CLDX YTD gains are higher at: 4.511 vs. CRNX (-20.086). CLDX has higher annual earnings (EBITDA): -231.4M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. CLDX (630M). CLDX has less debt than CRNX: CLDX (3.03M) vs CRNX (49.9M). CLDX has higher revenues than CRNX: CLDX (5.79M) vs CRNX (1.39M).
CLDXCRNXCLDX / CRNX
Capitalization1.75B3.85B46%
EBITDA-231.4M-419.62M55%
Gain YTD4.511-20.086-22%
P/E RatioN/AN/A-
Revenue5.79M1.39M416%
Total Cash630M1.2B53%
Total Debt3.03M49.9M6%
FUNDAMENTALS RATINGS
CLDX vs CRNX: Fundamental Ratings
CLDX
CRNX
OUTLOOK RATING
1..100
3070
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
7255
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
4342
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (55) in the Biotechnology industry is in the same range as CRNX (86) in the Pharmaceuticals Major industry. This means that CLDX’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (55) in the Pharmaceuticals Major industry is in the same range as CLDX (72) in the Biotechnology industry. This means that CRNX’s stock grew similarly to CLDX’s over the last 12 months.

CRNX's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as CLDX (97) in the Biotechnology industry. This means that CRNX’s stock grew similarly to CLDX’s over the last 12 months.

CRNX's Price Growth Rating (42) in the Pharmaceuticals Major industry is in the same range as CLDX (43) in the Biotechnology industry. This means that CRNX’s stock grew similarly to CLDX’s over the last 12 months.

CRNX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CLDX (100) in the Biotechnology industry. This means that CRNX’s stock grew similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXCRNX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMVVX29.280.17
+0.58%
Lord Abbett Focused Small Cap Value R5
MLVHX20.260.09
+0.45%
MFS Low Volatility Equity I
TRPIX48.910.18
+0.37%
T. Rowe Price Value I
FFECX15.040.05
+0.33%
Nuveen Dividend Value C
DPRIX74.670.16
+0.21%
BNY Mellon Worldwide Growth Y

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with CRNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+2.17%
CRNX - CLDX
51%
Loosely correlated
-1.57%
ARCT - CLDX
51%
Loosely correlated
+3.11%
BEAM - CLDX
51%
Loosely correlated
+0.63%
RVMD - CLDX
50%
Loosely correlated
+2.21%
XNCR - CLDX
50%
Loosely correlated
-0.42%
More